The prevalence and risk of human papillomavirus infection in pregnant women
- PMID: 24667102
- PMCID: PMC9151227
- DOI: 10.1017/S0950268814000636
The prevalence and risk of human papillomavirus infection in pregnant women
Abstract
A series of observational studies were evaluated concerning the risk of human papillomavirus (HPV) infection in pregnancy; however, the results were controversial. We systematically reviewed and collected data on studies regarding HPV prevalence published up to 30 April 2013, in which HPV was detected in pregnant women or both in pregnant and non-pregnant women. In total, 28 eligible studies were included that provided data on HPV infection concerning 13 640 pregnant women. The overall HPV prevalence in pregnant and age-matched non-pregnant women was 16·82% [95% confidence interval (CI) 16·21-17·47] and 12·25% (95% CI 11·50-13·01), respectively. The prevalence in the in three trimesters was 18·20%, 14·38%, and 19·32%, respectively. HPV-16 was the most frequently observed type, with a prevalence of 3·86% (95% CI 3·40-4·32). The overall HPV prevalence varied by study region, age, and HPV type. The meta-analysis showed a significantly increased risk of HPV infection in pregnant women, with a summary odds ratio (OR) of 1·42 (95% CI 1·25-1·61), especially for those aged <25 years (OR 1·79, 95% CI 1·22-2·63). The results suggest that pregnant women, especially those aged <25 years, are more susceptible to HPV infection.
Figures




Similar articles
-
Prevalence of human papillomavirus infection in pregnant versus non-pregnant women in Brazil.Arch Gynecol Obstet. 2015 Dec;292(6):1273-8. doi: 10.1007/s00404-015-3752-8. Epub 2015 May 20. Arch Gynecol Obstet. 2015. PMID: 25990479
-
High-risk human papillomavirus detection and related risk factors among pregnant and nonpregnant women in Mexico.Sex Transm Dis. 2005 Oct;32(10):613-8. doi: 10.1097/01.olq.0000179888.47309.db. Sex Transm Dis. 2005. PMID: 16205302
-
Genotype Distribution and Prevalence of High-Risk Human Papillomavirus among Pregnant Women and Maternal-Fetal Pregnancy Outcomes in a Tertiary Hospital in Beijing, China.Discov Med. 2024 May;36(184):981-991. doi: 10.24976/Discov.Med.202436184.91. Discov Med. 2024. PMID: 38798257
-
Human Papillomavirus Infection Among Pregnant Women Living With HIV: A Systematic Review and Meta-Analysis.J Acquir Immune Defic Syndr. 2022 Oct 1;91(2):122-129. doi: 10.1097/QAI.0000000000003050. J Acquir Immune Defic Syndr. 2022. PMID: 36094477
-
Molecular epidemiology of human papillomavirus among HIV infected women in developing countries: systematic review and meta-analysis.Virol J. 2020 Nov 16;17(1):179. doi: 10.1186/s12985-020-01448-1. Virol J. 2020. PMID: 33198743 Free PMC article.
Cited by
-
Human Papillomavirus (HPV) Infection in Early Pregnancy: Prevalence and Implications.Infect Dis Obstet Gynecol. 2019 Mar 24;2019:4376902. doi: 10.1155/2019/4376902. eCollection 2019. Infect Dis Obstet Gynecol. 2019. PMID: 31019362 Free PMC article.
-
The association between adverse pregnancy outcomes and maternal human papillomavirus infection: a systematic review protocol.Syst Rev. 2017 Mar 11;6(1):53. doi: 10.1186/s13643-017-0443-5. Syst Rev. 2017. PMID: 28284227 Free PMC article.
-
Papillomavirus Infection as Potential Cause of Miscarriage in the Early Gestational Age: A Prospective Study.Diagnostics (Basel). 2023 May 8;13(9):1659. doi: 10.3390/diagnostics13091659. Diagnostics (Basel). 2023. PMID: 37175050 Free PMC article.
-
HPV-associated vulvar carcinoma with sebaceous differentiation.Gynecol Oncol Rep. 2023 Oct 25;50:101298. doi: 10.1016/j.gore.2023.101298. eCollection 2023 Dec. Gynecol Oncol Rep. 2023. PMID: 37965381 Free PMC article.
-
Human Papillomavirus E6/E7 Expression in Preeclampsia-Affected Placentae.Pathogens. 2020 Mar 23;9(3):239. doi: 10.3390/pathogens9030239. Pathogens. 2020. PMID: 32209998 Free PMC article.
References
-
- Munoz N, et al. International Agency for Research on Cancer Multicenter cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New England Journal of Medicine 2003; 348: 518–527. - PubMed
-
- Remmink AJ, et al. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. International Journal of Cancer 1995; 61: 306–311. - PubMed
-
- Hobbs C, et al. Human papillomavirus and head and neck cancer: a systematic review and meta-analysis. Clinical Otolaryngology 2006; 31: 259–266. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous